Wall Street Analysts Predict a 281.43% Upside in AlloVir, Inc. (ALVR): Here's What You Should Know

Zacks Investment Research | 16:18 Fri 10 Feb 2023

Read More →

AlloVir, Inc. (ALVR) Upgraded to Buy: Here's What You Should Know

Zacks Investment Research | 18:32 Wed 25 Jan 2023

Read More →

How Much Upside is Left in AlloVir, Inc. (ALVR)? Wall Street Analysts Think 355.8%

Zacks Investment Research | 16:18 Wed 25 Jan 2023

Read More →

AlloVir to Present at the 41st Annual J.P. Morgan Healthcare Conference

Business Wire | 12:00 Tue 3 Jan 2023

Read More →

AlloVir: Solid Data, But Market Isn't Paying Attention

Seeking Alpha | 18:27 Thu 10 Nov 2022

Read More →

AlloVir to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Business Wire | 13:00 Wed 31 Aug 2022

Read More →